登录新浪财经APP 搜索【信披】查看更多考评等级 证券简称：瑞和股份 证券代码：002620 公告编号：2025-025 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗漏。 根据《深圳证券交易所股票上市规则》、《深圳证券交易所上市公司自律监管指引第3号——行业信息 披露》等相关规定，深圳瑞和建筑装饰股份有限公司（以下简称"公司"）现将2025年第一季度装修装饰 业务主要经营情况公告如下： 一、按业务类型分类订单汇总表 单位：万元 注：根据最新《深圳证券交易所股票上市规则》、《深圳证券交易所上市公司自律监管指引第3号—— 行业信息披露》等相关规定，上市公司应当披露公司"上一季度截至报告期末累计已签约未完工的合同 金额（不含已完工部分）"，区分于公司以往披露的装修装饰业务主要经营情况简报中"上一季度截至报 告期末累计已签约未完工的合同金额（含已完工部分）"。敬请投资者注意区分，并注意投资风险。 董事会 二○二五年四月二十七日 证券代码：002620 证券简称：瑞和股份 公告编号：2025-029 深圳瑞和建筑装饰股份有限公司 2024年年度报告摘要 一、重要提示 特此公告。 ...

Core Viewpoint - The supervisory board of Hualan Biological Engineering Co., Ltd. held its 15th meeting of the 8th session, approving several key proposals including the annual report, profit distribution plan, and changes in accounting policies, all of which will be submitted for shareholder approval at the upcoming annual general meeting [1][2][3]. Meeting Overview - The meeting was held on March 28, 2025, with all three supervisory board members present, complying with legal and regulatory requirements [1]. Resolutions Passed - The supervisory board approved the 2024 Annual Work Report, which will be submitted for shareholder review [2]. - The 2024 Annual Report and its summary were also approved, confirming that the report accurately reflects the company's situation without any misleading statements [2]. - The 2024 Financial Settlement Report was approved, pending shareholder approval [2]. - A profit distribution plan was approved, proposing a cash dividend of 2 yuan per 10 shares, totaling approximately 365.76 million yuan, with remaining undistributed profits rolling over to the next year [2][3]. - Changes to accounting policies and estimates were approved, ensuring compliance with the latest accounting standards without significantly impacting the company's financial status [3][4]. - The 2024 Internal Control Self-Evaluation Report was approved, indicating a robust internal control system in place [4]. - The proposal to use idle funds for investment and financial management was approved, aimed at improving fund utilization efficiency [5]. - The reappointment of the auditing firm for 2025 was approved, pending shareholder approval [5]. - The proposal to repurchase and cancel certain restricted stock options from the 2023 incentive plan was approved, ensuring compliance with relevant regulations [6]. - A proposal to amend the company's registered capital and related articles in the Articles of Association was approved, pending shareholder approval [6][7]. - The establishment of a Public Opinion Management System and a Market Value Management System was approved [7].